{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:07:47Z","timestamp":1787612867879,"version":"build-2736575974"},"reference-count":149,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2017,2,18]],"date-time":"2017-02-18T00:00:00Z","timestamp":1487376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atrial fibrillation (AF) is the most prevalent sustained arrhythmia found in clinical practice. AF rarely exists as a single entity but rather as part of a diverse clinical spectrum of cardiovascular diseases, related to structural and electrical remodeling within the left atrium, leading to AF onset, perpetuation, and progression. Due to the high overall prevalence within the AF population arterial hypertension plays a significant role in the pathogenesis of AF and its complications. Fibroblast proliferation, apoptosis of cardiomyocytes, gap junction remodeling, accumulation of collagen both in atrial and ventricular myocardium all accompany ageing-related structural remodeling with impact on electrical activity. The presence of hypertension also stimulates oxidative stress, systemic inflammation, rennin\u2013angiotensin\u2013aldosterone and sympathetic activation, which further drives the remodeling process in AF. Importantly, both hypertension and AF independently increase the risk of cardiovascular and cerebrovascular events, e.g., stroke and myocardial infarction. Given that both AF and hypertension often present with limited on patient wellbeing, treatment may be delayed resulting in development of complications as the first clinical manifestation of the disease. Antithrombotic prevention in AF combined with strict blood pressure control is of primary importance, since stroke risk and bleeding risk are both greater with underlying hypertension.<\/jats:p>","DOI":"10.1093\/ajh\/hpx013","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T08:25:10Z","timestamp":1485764710000},"page":"733-755","source":"Crossref","is-referenced-by-count":79,"title":["Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes"],"prefix":"10.1093","volume":"30","author":[{"given":"Mikhail S.","family":"Dzeshka","sequence":"first","affiliation":[{"name":"University of Birmingham Institute of Cardiovascular Sciences, City Hospital 1 , Birmingham , UK"},{"name":"Grodno State Medical University 2 , Grodno , Belarus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Shahid","sequence":"additional","affiliation":[{"name":"University of Birmingham Institute of Cardiovascular Sciences, City Hospital 1 , Birmingham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Shantsila","sequence":"additional","affiliation":[{"name":"University of Birmingham Institute of Cardiovascular Sciences, City Hospital 1 , Birmingham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[{"name":"University of Birmingham Institute of Cardiovascular Sciences, City Hospital 1 , Birmingham , UK"},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University 3 , Aalborg , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,18]]},"reference":[{"key":"2022111818322516500_CIT0001","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2022111818322516500_CIT0002","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2014.01.023","article-title":"Lone atrial fibrillation: does it exist?","volume":"63","author":"Wyse","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022111818322516500_CIT0003","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/ijcp.12281","article-title":"Lone atrial fibrillation\u2014an overview","volume":"68","author":"Potpara","year":"2014","journal-title":"Int J Clin Pract"},{"key":"2022111818322516500_CIT0004","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ahj.2016.03.023","article-title":"Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study)","volume":"177","author":"Kim","year":"2016","journal-title":"Am Heart J"},{"key":"2022111818322516500_CIT0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2016.01.007","article-title":"Atrial fibrillation and arterial hypertension: a common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role","volume":"206","author":"Seccia","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022111818322516500_CIT0006","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ Res"},{"key":"2022111818322516500_CIT0007","first-page":"e38","article-title":"Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"2022111818322516500_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-014-0446-8","article-title":"Cardiac target organ damage in hypertension: insights from epidemiology","volume":"16","author":"Lawler","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"2022111818322516500_CIT0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-016-0669-y","article-title":"Changes in hypertension prevalence, awareness, treatment, and control in high-, middle-, and low-income countries: an update","volume":"18","author":"Cifkova","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"2022111818322516500_CIT0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"2022111818322516500_CIT0011","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(16)00002-7","article-title":"From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century","volume":"388","author":"Blacher","year":"2016","journal-title":"Lancet"},{"key":"2022111818322516500_CIT0012","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"2022111818322516500_CIT0013","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"2022111818322516500_CIT0014","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"2022111818322516500_CIT0015","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"2022111818322516500_CIT0016","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"2022111818322516500_CIT0017","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/joim.12478","article-title":"The changing circumstance of atrial fibrillation\u2014progress towards precision medicine","volume":"279","author":"Camm","year":"2016","journal-title":"J Intern Med"},{"key":"2022111818322516500_CIT0018","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ccl.2015.12.002","article-title":"The epidemiology of atrial fibrillation and stroke","volume":"34","author":"Pistoia","year":"2016","journal-title":"Cardiol Clin"},{"key":"2022111818322516500_CIT0019","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"2022111818322516500_CIT0020","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"2022111818322516500_CIT0021","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH13-02-0165","article-title":"Screening to identify unknown atrial fibrillation. A systematic review","volume":"110","author":"Lowres","year":"2013","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0022","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1160\/TH14-03-0231","article-title":"Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study","volume":"111","author":"Lowres","year":"2014","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0023","doi-asserted-by":"crossref","first-page":"e003333","DOI":"10.1161\/CIRCEP.115.003333","article-title":"Uncovering atrial fibrillation beyond short-term monitoring in cryptogenic stroke patients: three-year results from the cryptogenic stroke and underlying atrial fibrillation trial","volume":"9","author":"Brachmann","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022111818322516500_CIT0024","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/hrt.2006.110791","article-title":"Atrial fibrillation\u2013the growing epidemic","volume":"93","author":"Lip","year":"2007","journal-title":"Heart"},{"key":"2022111818322516500_CIT0025","first-page":"247","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterisation, and clinical implication","volume":"32","author":"Goette","year":"2016","journal-title":"Europace"},{"key":"2022111818322516500_CIT0026","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","article-title":"Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications","volume":"66","author":"Dzeshka","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022111818322516500_CIT0027","doi-asserted-by":"crossref","first-page":"798768","DOI":"10.1155\/2015\/798768","article-title":"Atrial fibrillation and fibrosis: beyond the cardiomyocyte centric view","volume":"2015","author":"Miragoli","year":"2015","journal-title":"Biomed Res Int"},{"key":"2022111818322516500_CIT0028","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/jce.13049","article-title":"Increased susceptibility to atrial fibrillation secondary to atrial fibrosis in transgenic goats expressing transforming growth factor-\u03b21","volume":"27","author":"Polejaeva","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022111818322516500_CIT0029","doi-asserted-by":"crossref","first-page":"e0155275","DOI":"10.1371\/journal.pone.0155275","article-title":"Association of plasma transforming growth factor-\u03b21 levels and the risk of atrial fibrillation: a meta-analysis","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"2022111818322516500_CIT0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/ehw119","article-title":"Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation","volume":"38","author":"Spronk","year":"2017","journal-title":"Eur Heart J"},{"key":"2022111818322516500_CIT0031","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.107.748053","article-title":"Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences","volume":"117","author":"Burstein","year":"2008","journal-title":"Circulation"},{"key":"2022111818322516500_CIT0032","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/cvr\/cvv275","article-title":"The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis","volume":"109","author":"Heijman","year":"2016","journal-title":"Cardiovasc Res"},{"key":"2022111818322516500_CIT0033","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.114.302226","article-title":"Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression","volume":"114","author":"Heijman","year":"2014","journal-title":"Circ Res"},{"key":"2022111818322516500_CIT0034","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jacc.2013.09.020","article-title":"Atrial autonomic innervation: a target for interventional antiarrhythmic therapy?","volume":"63","author":"Linz","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022111818322516500_CIT0035","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1161\/01.CIR.0000018443.44005.D8","article-title":"Autonomic tone variations before the onset of paroxysmal atrial fibrillation","volume":"105","author":"Bettoni","year":"2002","journal-title":"Circulation"},{"key":"2022111818322516500_CIT0036","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jacc.2007.03.045","article-title":"Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure","volume":"50","author":"Ogawa","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022111818322516500_CIT0037","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1540-8159.2006.00447.x","article-title":"Evidence for increased atrial sympathetic innervation in persistent human atrial fibrillation","volume":"29","author":"Gould","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"2022111818322516500_CIT0038","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijcard.2015.08.108","article-title":"Vagal atrial fibrillation: what is it and should we treat it?","volume":"201","author":"Carpenter","year":"2015","journal-title":"Int J Cardiol"},{"key":"2022111818322516500_CIT0039","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mcna.2016.08.017","article-title":"Local renin angiotensin aldosterone systems and cardiovascular diseases","volume":"101","author":"De Mello","year":"2017","journal-title":"Med Clin North Am"},{"key":"2022111818322516500_CIT0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mcna.2016.08.009","article-title":"The renin angiotensin aldosterone system in obesity and hypertension: roles in the cardiorenal metabolic syndrome","volume":"101","author":"Cabandugama","year":"2017","journal-title":"Med Clin North Am"},{"key":"2022111818322516500_CIT0041","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/jce.12553","article-title":"Renal denervation for treatment of cardiac arrhythmias: state of the art and future directions","volume":"26","author":"Kosiuk","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022111818322516500_CIT0042","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.hrthm.2010.05.010","article-title":"Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model","volume":"7","author":"Lau","year":"2010","journal-title":"Heart Rhythm"},{"key":"2022111818322516500_CIT0043","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.hrthm.2009.11.031","article-title":"Short-term hypertension is associated with the development of atrial fibrillation substrate: a study in an ovine hypertensive model","volume":"7","author":"Lau","year":"2010","journal-title":"Heart Rhythm"},{"key":"2022111818322516500_CIT0044","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/HYPERTENSIONAHA.116.07650","article-title":"Relations of arterial stiffness and brachial flow-mediated dilation with new-onset atrial fibrillation: the Framingham Heart study","volume":"68","author":"Shaikh","year":"2016","journal-title":"Hypertension"},{"key":"2022111818322516500_CIT0045","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/heartjnl-2015-307438","article-title":"Association between diastolic dysfunction and future atrial fibrillation in the Troms\u00f8 Study from 1994 to 2010","volume":"101","author":"Tiwari","year":"2015","journal-title":"Heart"},{"key":"2022111818322516500_CIT0046","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jjcc.2013.06.019","article-title":"Elevated left ventricular filling pressure estimated by E\/E\u2019 ratio after exercise predicts development of new-onset atrial fibrillation independently of left atrial enlargement among elderly patients without obvious myocardial ischemia","volume":"63","author":"Takagi","year":"2014","journal-title":"J Cardiol"},{"key":"2022111818322516500_CIT0047","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/pace.12907","article-title":"Atrial fibrillation and cardiovascular outcomes in the elderly","volume":"39","author":"O\u2019Neal","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"2022111818322516500_CIT0048","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyw053","article-title":"Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults","author":"Emdin","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2022111818322516500_CIT0049","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ijcard.2016.08.090","article-title":"Mortality associated to atrial fibrillation still on the rise: United States, 1999 to 2014","volume":"222","author":"Fedeli","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022111818322516500_CIT0050","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"2022111818322516500_CIT0051","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"2022111818322516500_CIT0052","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/HJH.0000000000000378","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials","volume":"32","author":"Thomopoulos","year":"2014","journal-title":"J Hypertens"},{"key":"2022111818322516500_CIT0053","first-page":"49","article-title":"Stroke and bleeding risk assessment: where are we now?","volume":"6","author":"Dzeshka","year":"2014","journal-title":"J Atr Fibrillation"},{"key":"2022111818322516500_CIT0054","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.hfc.2015.08.021","article-title":"Antithrombotic and anticoagulant therapy for atrial fibrillation","volume":"12","author":"Dzeshka","year":"2016","journal-title":"Heart Fail Clin"},{"key":"2022111818322516500_CIT0055","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1160\/TH15-02-0154","article-title":"Stroke risk in atrial fibrillation: do we anticoagulate CHADS2 or CHA2DS2-VASc \u22651, or higher?","volume":"113","author":"Olesen","year":"2015","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0056","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1160\/TH15-03-0210","article-title":"The risks of risk scores for stroke risk assessment in atrial fibrillation","volume":"113","author":"Nielsen","year":"2015","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0057","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1474-4422(16)30073-4","article-title":"Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"15","author":"Feigin","year":"2016","journal-title":"Lancet Neurol"},{"key":"2022111818322516500_CIT0058","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"2022111818322516500_CIT0059","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/clc.22294","article-title":"Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2, CHA2 DS2 -VASc, R2 CHADS2, HAS-BLED, ATRIA, and more)","volume":"37","author":"Dzeshka","year":"2014","journal-title":"Clin Cardiol"},{"key":"2022111818322516500_CIT0060","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1160\/TH15-03-0222","article-title":"Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants","volume":"114","author":"Weitz","year":"2015","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0061","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.thromres.2014.06.003","article-title":"Specific risk scores for specific purposes: use CHA2DS2-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation","volume":"134","author":"Dzeshka","year":"2014","journal-title":"Thromb Res"},{"key":"2022111818322516500_CIT0062","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1160\/TH15-02-0116","article-title":"Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry","volume":"114","author":"Michalski","year":"2015","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0063","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1160\/TH15-12-1000","article-title":"Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation","volume":"116","author":"Kittelson","year":"2016","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0064","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1160\/TH16-05-0403","article-title":"Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis","volume":"116","author":"Lip","year":"2016","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0065","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1160\/TH16-03-0203","article-title":"Dabigatran in real-world atrial fibrillation","volume":"116","author":"Carmo","year":"2016","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0066","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1160\/TH15-06-0453","article-title":"A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system","volume":"114","author":"Villines","year":"2015","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0067","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1160\/TH15-06-0497","article-title":"Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation","volume":"114","author":"Seeger","year":"2015","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0068","article-title":"Control of anticoagulation with vitamin K antagonists: overestimation of median time in therapeutic range when assessed by linear interpolation","volume":"116","author":"Biedermann","year":"2016","journal-title":"Thromb haemost"},{"key":"2022111818322516500_CIT0069","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT\u2082R\u2082 score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"key":"2022111818322516500_CIT0070","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1160\/TH16-01-0025","article-title":"Quality and predictors of anticoagulant control with vitamin K antagonist for stroke prevention in atrial fibrillation","volume":"116","author":"Wilson","year":"2016","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0071","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1160\/TH15-02-0169","article-title":"Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists","volume":"114","author":"Ruiz-Ortiz","year":"2015","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0072","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1160\/TH4-04-0383","article-title":"Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study","volume":"112","author":"Martinez","year":"2014","journal-title":"Thromb Haemost"},{"key":"2022111818322516500_CIT0073","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(15)70027-X","article-title":"Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis","volume":"14","author":"Sposato","year":"2015","journal-title":"Lancet Neurol"},{"key":"2022111818322516500_CIT0074","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10840-013-9863-x","article-title":"Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation: systematic review and meta-analysis","volume":"39","author":"Lin","year":"2014","journal-title":"J Interv Card Electrophysiol"},{"key":"2022111818322516500_CIT0075","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1540-8167.2010.01798.x","article-title":"Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review","volume":"21","author":"Balk","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022111818322516500_CIT0076","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022111818322516500_CIT0077","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/europace\/eut152","article-title":"Lone atrial fibrillation as a positive predictor of left atrial volume reduction following ablation of atrial fibrillation","volume":"16","author":"Fredersdorf","year":"2014","journal-title":"Europace"},{"key":"2022111818322516500_CIT0078","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10840-012-9690-5","article-title":"Acute safety outcomes in younger and older patients with atrial fibrillation treated with catheter ablation","volume":"35","author":"Hao","year":"2012","journal-title":"J Interv Card Electrophysiol"},{"key":"2022111818322516500_CIT0079","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijcard.2014.04.011","article-title":"Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapy","volume":"174","author":"Shah","year":"2014","journal-title":"Int J Cardiol"},{"key":"2022111818322516500_CIT0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.amjcard.2014.05.012","article-title":"Effect of left ventricular diastolic dysfunction on outcomes of atrial fibrillation ablation","volume":"114","author":"Kumar","year":"2014","journal-title":"Am J Cardiol"},{"key":"2022111818322516500_CIT0081","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation","volume":"55","author":"de Vos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2022111818322516500_CIT0082","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ahj.2012.02.015","article-title":"Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy","volume":"163","author":"De Vos","year":"2012","journal-title":"Am Heart J"},{"key":"2022111818322516500_CIT0083","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.hrthm.2015.04.008","article-title":"HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter","volume":"12","author":"Chen","year":"2015","journal-title":"Heart Rhythm"},{"key":"2022111818322516500_CIT0084","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.hrthm.2015.07.003","article-title":"Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score","volume":"12","author":"Kosiuk","year":"2015","journal-title":"Heart Rhythm"},{"key":"2022111818322516500_CIT0085","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.hrthm.2016.07.018","article-title":"Predicting atrial fibrillation ablation outcome: The CAAP-AF score","volume":"13","author":"Winkle","year":"2016","journal-title":"Heart Rhythm"},{"key":"2022111818322516500_CIT0086","doi-asserted-by":"crossref","first-page":"e000102","DOI":"10.1161\/JAHA.112.000102","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2022111818322516500_CIT0087","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"2022111818322516500_CIT0088","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.amjcard.2010.08.049","article-title":"A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study)","volume":"107","author":"Chamberlain","year":"2011","journal-title":"Am J Cardiol"},{"key":"2022111818322516500_CIT0089","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/CIRCULATIONAHA.108.830042","article-title":"Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women","volume":"119","author":"Conen","year":"2009","journal-title":"Circulation"},{"key":"2022111818322516500_CIT0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/HYPERTENSIONAHA.111.179713","article-title":"Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study","volume":"59","author":"Grundvold","year":"2012","journal-title":"Hypertension"},{"key":"2022111818322516500_CIT0091","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1161\/CIRCULATIONAHA.110.958306","article-title":"European ancestry as a risk factor for atrial fibrillation in African Americans","volume":"122","author":"Marcus","year":"2010","journal-title":"Circulation"},{"key":"2022111818322516500_CIT0092","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.297.7.709","article-title":"Pulse pressure and risk of new-onset atrial fibrillation","volume":"297","author":"Mitchell","year":"2007","journal-title":"JAMA"},{"key":"2022111818322516500_CIT0093","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/2047487312446562","article-title":"Palpitations are predictive of future atrial fibrillation. An 11-year follow-up of 22,815 men and women: the Troms\u00f8 Study","volume":"20","author":"Nyrnes","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"2022111818322516500_CIT0094","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.amjcard.2015.09.024","article-title":"Relation of risk of atrial fibrillation with systolic blood pressure response during exercise stress testing (from the Henry Ford ExercIse Testing Project)","volume":"116","author":"O\u2019Neal","year":"2015","journal-title":"Am J Cardiol"},{"key":"2022111818322516500_CIT0095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/HYPERTENSIONAHA.115.05728","article-title":"Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients","volume":"66","author":"Okin","year":"2015","journal-title":"Hypertension"},{"key":"2022111818322516500_CIT0096","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.amjcard.2014.05.041","article-title":"Relation of systolic, diastolic, and pulse pressures and aortic distensibility with atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis)","volume":"114","author":"Roetker","year":"2014","journal-title":"Am J Cardiol"},{"key":"2022111818322516500_CIT0097","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/eurheartj\/ehp076","article-title":"Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men","volume":"30","author":"Rosengren","year":"2009","journal-title":"Eur Heart J"},{"key":"2022111818322516500_CIT0098","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"key":"2022111818322516500_CIT0099","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/archinternmed.2010.434","article-title":"Validation of an atrial fibrillation risk algorithm in whites and African Americans","volume":"170","author":"Schnabel","year":"2010","journal-title":"Arch Intern Med"},{"key":"2022111818322516500_CIT0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10654-009-9404-1","article-title":"Atrial fibrillation in the Malm\u00f6 Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity","volume":"25","author":"Smith","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"2022111818322516500_CIT0101","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4070\/kcj.2016.46.4.515","article-title":"Incidence and risk factors for atrial fibrillation in Korea: the National Health Insurance Service Database (2002-2010)","volume":"46","author":"Son","year":"2016","journal-title":"Korean Circ J"},{"key":"2022111818322516500_CIT0102","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ajh.2008.248","article-title":"Blood pressure control and risk of incident atrial fibrillation","volume":"21","author":"Thomas","year":"2008","journal-title":"Am J Hypertens"},{"key":"2022111818322516500_CIT0103","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.HYP.0000052830.02773.E4","article-title":"Atrial fibrillation in hypertension: predictors and outcome","volume":"41","author":"Verdecchia","year":"2003","journal-title":"Hypertension"},{"key":"2022111818322516500_CIT0104","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/HJH.0b013e3283522a51","article-title":"Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the ongoing telmisartan alone and in combination with Ramipril Global Endpoint Trial\/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies","volume":"30","author":"Verdecchia","year":"2012","journal-title":"J Hypertens"},{"key":"2022111818322516500_CIT0105","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jacc.2015.06.1314","article-title":"Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands","volume":"66","author":"Vermond","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022111818322516500_CIT0106","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2022111818322516500_CIT0107","doi-asserted-by":"crossref","first-page":"e78218","DOI":"10.1371\/journal.pone.0078218","article-title":"Catheter-based renal sympathetic denervation significantly inhibits atrial fibrillation induced by electrical stimulation of the left stellate ganglion and rapid atrial pacing","volume":"8","author":"Hou","year":"2013","journal-title":"PLoS One"},{"key":"2022111818322516500_CIT0108","doi-asserted-by":"crossref","first-page":"e0124123","DOI":"10.1371\/journal.pone.0124123","article-title":"Renal denervation suppresses atrial fibrillation in a model of renal impairment","volume":"10","author":"Liang","year":"2015","journal-title":"PLoS One"},{"key":"2022111818322516500_CIT0109","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.111.00182","article-title":"Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation","volume":"61","author":"Linz","year":"2013","journal-title":"Hypertension"},{"key":"2022111818322516500_CIT0110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.113.01728","article-title":"Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea","volume":"62","author":"Linz","year":"2013","journal-title":"Hypertension"},{"key":"2022111818322516500_CIT0111","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCEP.114.002453","article-title":"Catheter-based renal denervation reduces atrial nerve sprouting and complexity of atrial fibrillation in goats","volume":"8","author":"Linz","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022111818322516500_CIT0112","doi-asserted-by":"crossref","first-page":"e64611","DOI":"10.1371\/journal.pone.0064611","article-title":"Effect of renal sympathetic denervation on atrial substrate remodeling in ambulatory canines with prolonged atrial pacing","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"2022111818322516500_CIT0113","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/pace.12429","article-title":"Effects of renal sympathetic denervation on the atrial electrophysiology in dogs with pacing-induced heart failure","volume":"37","author":"Wang","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2022111818322516500_CIT0114","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/europace\/euu212","article-title":"Effect of renal sympathetic denervation on the progression of paroxysmal atrial fibrillation in canines with long-term intermittent atrial pacing","volume":"17","author":"Wang","year":"2015","journal-title":"Europace"},{"key":"2022111818322516500_CIT0115","doi-asserted-by":"crossref","first-page":"e0160634","DOI":"10.1371\/journal.pone.0160634","article-title":"Renal denervation suppresses the inducibility of atrial fibrillation in a Rabbit Model for atrial fibrosis","volume":"11","author":"Wei","year":"2016","journal-title":"PLoS One"},{"key":"2022111818322516500_CIT0116","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10840-012-9717-y","article-title":"Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing","volume":"35","author":"Zhao","year":"2012","journal-title":"J Interv Card Electrophysiol"},{"key":"2022111818322516500_CIT0117","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2015.10.120","article-title":"Renal sympathetic denervation suppresses atrial fibrillation induced by acute atrial ischemia\/infarction through inhibition of cardiac sympathetic activity","volume":"203","author":"Zhou","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022111818322516500_CIT0118","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.hrthm.2015.01.039","article-title":"Reverse cardiac remodeling after renal denervation: Atrial electrophysiologic and structural changes associated with blood pressure lowering","volume":"12","author":"McLellan","year":"2015","journal-title":"Heart Rhythm"},{"key":"2022111818322516500_CIT0119","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jacc.2012.05.036","article-title":"A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension","volume":"60","author":"Pokushalov","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2022111818322516500_CIT0120","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.hrthm.2014.03.055","article-title":"Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience","volume":"11","author":"Pokushalov","year":"2014","journal-title":"Heart Rhythm"},{"key":"2022111818322516500_CIT0121","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jcin.2015.02.014","article-title":"Atrial remodeling following catheter-based renal denervation occurs in a blood pressure- and heart Rate-Independent Manner","volume":"8","author":"Schirmer","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"2022111818322516500_CIT0122","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2022111818322516500_CIT0123","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"2022111818322516500_CIT0124","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijcard.2016.08.222","article-title":"Delayed recurrence of atrial fibrillation 2years after catheter ablation is associated with metabolic syndrome","volume":"223","author":"Baek","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022111818322516500_CIT0125","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/jce.12116","article-title":"Left atrial sphericity: a new method to assess atrial remodeling. Impact on the outcome of atrial fibrillation ablation","volume":"24","author":"Bisbal","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022111818322516500_CIT0126","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/pace.12420","article-title":"Association of quality of life, anxiety, and depression with left atrial ablation outcomes","volume":"37","author":"Efremidis","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2022111818322516500_CIT0127","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.amjcard.2012.04.028","article-title":"Predictors of atrial fibrillation termination and clinical success of catheter ablation of persistent atrial fibrillation","volume":"110","author":"Heist","year":"2012","journal-title":"Am J Cardiol"},{"key":"2022111818322516500_CIT0128","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4070\/kcj.2011.41.4.177","article-title":"Association between plaque thickness of the thoracic aorta and recurrence of atrial fibrillation after ablation","volume":"41","author":"Hwang","year":"2011","journal-title":"Korean Circ J"},{"key":"2022111818322516500_CIT0129","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1536\/ihj.13-370","article-title":"The difference of predictors for recurrence after catheter ablation of non-paroxysmal atrial fibrillation according to follow-up period","volume":"55","author":"Kim","year":"2014","journal-title":"Int Heart J"},{"key":"2022111818322516500_CIT0130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/jce.12088","article-title":"Inducibility of atrial fibrillation and flutter following pulmonary vein ablation","volume":"24","author":"Leong-Sit","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022111818322516500_CIT0131","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2011.06.092","article-title":"The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation","volume":"164","author":"Letsas","year":"2013","journal-title":"Int J Cardiol"},{"key":"2022111818322516500_CIT0132","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3760\/cma.j.issn.0366-6999.20123406","article-title":"Outcome of catheter ablation of atrial fibrillation in patients with prior ischemic stroke","volume":"126","author":"Li","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"2022111818322516500_CIT0133","first-page":"120","article-title":"Long-term results of single-procedure catheter ablation for atrial fibrillationin pre- and post-menopausal women","volume":"11","author":"Lin","year":"2014","journal-title":"J Geriatr Cardiol"},{"key":"2022111818322516500_CIT0134","first-page":"291","article-title":"Catheter ablation of atrial fibrillation in the elderly","volume":"11","author":"Lioni","year":"2014","journal-title":"J Geriatr Cardiol"},{"key":"2022111818322516500_CIT0135","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5603\/CJ.a2013.0144","article-title":"Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up","volume":"21","author":"Lodzi\u0144ski","year":"2014","journal-title":"Cardiol J"},{"key":"2022111818322516500_CIT0136","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jacc.2013.07.020","article-title":"Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction","volume":"62","author":"Machino-Ohtsuka","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022111818322516500_CIT0137","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1540-8167.2010.01984.x","article-title":"Preprocedural predictors of atrial fibrillation recurrence following pulmonary vein antrum isolation in patients with paroxysmal atrial fibrillation: long-term follow-up results","volume":"22","author":"Miyazaki","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022111818322516500_CIT0138","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1540-8159.2012.03487.x","article-title":"Impact of the preprocedural frequency of paroxysmal atrial fibrillation on the clinical outcome after catheter ablation","volume":"35","author":"Miyazaki","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"2022111818322516500_CIT0139","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ehjci\/jet194","article-title":"Left atrial size and function by three-dimensional echocardiography to predict arrhythmia recurrence after first and repeated ablation of atrial fibrillation","volume":"15","author":"Montserrat","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022111818322516500_CIT0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmg.2013.08.013","article-title":"Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation","volume":"7","author":"Neilan","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022111818322516500_CIT0141","doi-asserted-by":"crossref","first-page":"e001277","DOI":"10.1161\/JAHA.114.001277","article-title":"Prolonged PR interval predicts clinical recurrence of atrial fibrillation after catheter ablation","volume":"3","author":"Park","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2022111818322516500_CIT0142","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10840-015-0060-y","article-title":"Poor scar formation after ablation is associated with atrial fibrillation recurrence","volume":"44","author":"Parmar","year":"2015","journal-title":"J Interv Card Electrophysiol"},{"key":"2022111818322516500_CIT0143","first-page":"164","article-title":"Impact of uncontrolled hypertension on atrial fibrillation ablation outcome","volume":"1","author":"Santoro","journal-title":"JACC"},{"key":"2022111818322516500_CIT0144","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/europace\/eut076","article-title":"Incidence and risk factors for very late recurrence of atrial fibrillation after radiofrequency catheter ablation","volume":"15","author":"Sotomi","year":"2013","journal-title":"Europace"},{"key":"2022111818322516500_CIT0145","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.hrthm.2014.02.003","article-title":"Very long-term outcome after initially successful catheter ablation of atrial fibrillation","volume":"11","author":"Steinberg","year":"2014","journal-title":"Heart Rhythm"},{"key":"2022111818322516500_CIT0146","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/1470320312446212","article-title":"Renin-angiotensin system inhibitors can suppress atrial fibrillation recurrence after encircling ipsilateral pulmonary vein isolation in patients with a non-dilated left atrium","volume":"13","author":"Takigawa","year":"2012","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2022111818322516500_CIT0147","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/europace\/euv439","article-title":"Five-year efficacy of pulmonary vein antrum isolation as a primary ablation strategy for atrial fibrillation: a single-centre cohort study","volume":"18","author":"Teunissen","year":"2016","journal-title":"Europace"},{"key":"2022111818322516500_CIT0148","first-page":"913","article-title":"The impact of hypertension on the electromechanical properties and outcome of catheter ablation in atrial fibrillation patients","volume":"6","author":"Wang","year":"2014","journal-title":"J Thorac Dis"},{"key":"2022111818322516500_CIT0149","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1253\/circj.CJ-13-0275","article-title":"Ipsilateral circumferential radiofrequency ablation of atrial fibrillation with irrigated tip catheter: long-term outcome and pre-procedural predictors","volume":"77","author":"W\u00f3jcik","year":"2013","journal-title":"Circ J"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/30\/8\/733\/47137156\/ajh_30_8_733.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/30\/8\/733\/47137156\/ajh_30_8_733.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:24:35Z","timestamp":1719015875000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/30\/8\/733\/3015740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,18]]},"references-count":149,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,2,18]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpx013","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,2,18]]}}}